GoodRx Holdings annual net debt
2019
2020
2021
2022
2023
2024
2025
GoodRx Holdings Net Debt Growth & History (GDRX)
GoodRx Holdings's net debt was $281.0M for fiscal 2025.
View full GoodRx Holdings company overviewGoodRx Holdings annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $281.0M | $185.9M | +195.65% |
| 2024 | 2024-12-31 | $95.0M | $56.3M | +145.12% |
| 2023 | 2023-12-31 | $38.8M | $78.9M | — |
| 2022 | 2022-12-31 | −$40.1M | $198.6M | — |
| 2021 | 2021-12-31 | −$238.8M | $25.0M | — |
| 2020 | 2020-12-31 | −$263.8M | −$948.7M | — |
| 2019 | 2019-12-31 | $684.9M | — | — |
GoodRx Holdings quarterly net debt
Q4.19
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $242.8M | −$23.4M | −8.78% |
| Q1 2026 | 2026-03-31 | $305.6M | $65.4M | +27.24% |
| Q4 2025 | 2025-12-31 | $281.0M | $185.9M | +195.65% |
| Q3 2025 | 2025-09-30 | $271.6M | $150.8M | +124.86% |
| Q2 2025 | 2025-06-30 | $266.2M | $83.7M | +45.89% |
| Q1 2025 | 2025-03-31 | $240.2M | $63.3M | +35.80% |
| Q4 2024 | 2024-12-31 | $95.0M | $56.3M | +145.12% |
| Q3 2024 | 2024-09-30 | $120.8M | $204.2M | — |
| Q2 2024 | 2024-06-30 | $182.5M | $230.1M | — |
| Q1 2024 | 2024-03-31 | $176.9M | $222.0M | — |
| Q4 2023 | 2023-12-31 | $38.8M | $78.9M | — |
| Q3 2023 | 2023-09-30 | −$83.4M | −$53.1M | — |
| Q2 2023 | 2023-06-30 | −$47.6M | −$17.5M | — |
| Q1 2023 | 2023-03-31 | −$45.2M | $100.2M | — |
| Q4 2022 | 2022-12-31 | −$40.1M | $198.6M | — |
| Q3 2022 | 2022-09-30 | −$30.3M | $179.8M | — |
| Q2 2022 | 2022-06-30 | −$30.1M | $160.6M | — |
| Q1 2022 | 2022-03-31 | −$145.3M | $139.5M | — |
| Q4 2021 | 2021-12-31 | −$238.8M | $25.0M | — |
| Q3 2021 | 2021-09-30 | −$210.2M | $131.5M | — |
| Q2 2021 | 2021-06-30 | −$190.7M | — | — |
| Q1 2021 | 2021-03-31 | −$284.9M | — | — |
| Q4 2020 | 2020-12-31 | −$263.8M | −$948.7M | — |
| Q3 2020 | 2020-09-30 | −$341.7M | — | — |
| Q4 2019 | 2019-12-31 | $684.9M | — | — |
GoodRx Holdings net debt trends
Over the last five fiscal years, GoodRx Holdings's net debt increased from −$263.8M to $281.0M, a change of $544.8M. The latest reported quarter, Q2 2026, shows $242.8M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GoodRx Holdings source filings ↗